CRA International: The Expert Witness Economics Firm Hiding in Plain Sight

CRA International has been advising judges, juries, and regulators since 1965. Across offices in North America, Europe, and Asia-Pacific, 968 employees — economists, accountants, and management consultants — analyze damages in antitrust cases, reconstruct financial frauds, and model patent royalty rates for federal courts. The company generated $751.6 million in revenue in fiscal year 2025 and has grown at roughly 7% per year over the past four fiscal years.

Two Wall Street analyst ratings were publicly listed as of August 2026. [FMP] CRAI: analyst coverage, FMP

Annual financial figures cited in this analysis are sourced from SEC XBRL and the FMP profile in the data cache.

The coverage gap is structural, not accidental. Standard equity screeners classify CRAI as "Industrials — Consulting Services," the same category as staffing firms and general management advisors. That classification routes CRAI to generalist sector analysts who cover project-based consulting models. The analysts who understand litigation economics — where the product is testimony credibility, not a project deliverable — work at specialist coverage shops that rarely initiate on small-caps. The result is a $1.14 billion company with the coverage density of a much smaller name.

Coverage Gap

The screener label is the story. [FMP] CRAI: sector 'Industrials', industry 'Consulting Services'

When an equity screener places CRA International next to management advisory firms and IT staffing companies, several compounding filter-outs likely follow. Growth-oriented screens may skip on revenue CAGR — 7% over four years underperforms faster-growing sectors like technology or life sciences. Value screens may bypass the 21.7x trailing P/E as too expensive relative to undifferentiated service firms. Quality screens may flag OCF variability: CRA's operating cash flow ranged from $22.4 million to $75.7 million across the five years ended FY2025, a swing consistent with the timing patterns of compensation-heavy professional services firms — though a screening algorithm has no way to distinguish this from structural deterioration.

CRA's closest pure-play peers in litigation economics — Cornerstone Research and Analysis Group — are entirely private. FTI Consulting's Compass Lexecon division competes directly but reports as part of a larger multi-service firm, making clean comparison difficult. There is no public pure-play peer group from which to extrapolate CRA's business model, and no analyst can build a straightforward comp table when the dominant independent competitors file no public financials.

Business

CRA organizes its work across two primary service lines: litigation and regulatory consulting, and management consulting — though the company reports as a single operating segment (professional and consulting services), which is part of why the business resists standard analyst modeling. The former service line is the moat; the latter is the growth optionality.

Litigation and regulatory consulting deploys Ph.D. economists and forensic accountants in legal proceedings. Engagements span antitrust and competition economics, financial economics (securities litigation, valuation disputes), intellectual property (patent damages), labor and employment, life sciences (FDA regulatory economics), and forensic accounting and investigations. These engagements are initiated by law firms on behalf of corporate clients or government agencies. [SEC] CRA FY2025 10-K

Management consulting covers strategy, market research, valuation, ESG advisory, and auction design. This service line carries economics closer to conventional consulting — project-based, with lower structural switching costs.

Revenue grew from $565.9 million in FY2021 to $751.6 million in FY2025, a compound annual rate of approximately 7.4%. CRA operates in North America and internationally, including the United Kingdom. Individual expert contribution and practice-area attribution are not separately disclosed within the single-segment structure — limiting external modeling precision.

Moat / Mispricing

Expert witness relationships have a structural property that standard consulting does not: the testimony track record is an asset that compounds with use, not one that depletes.

An antitrust economist who has testified dozens of times before federal judges in class certification proceedings is not easily replaced. The law firms who retain that economist have built a body of cases citing that expert's prior testimony. The economist knows the judges' analytical preferences, knows the opposing firms' counterarguments, and has a public track record that opposing counsel cannot easily attack without attacking prior verdicts. Replacing that expert mid-engagement risks everything built. Replacing that expert across a client relationship means starting a new track record from zero.

This is qualitatively different from strategy consulting, where the deliverable is advice and the relationship resets with each new project. At CRA, the deliverable includes the credibility accumulated across all prior cases. That credibility is not on the balance sheet and does not appear in any financial ratio.

Cornerstone Research and Analysis Group have built exactly this model and remain private. FTI Consulting's Compass Lexecon division operates similarly within a larger corporate structure. CRA, as one of the few publicly traded pure-play litigation economics firms, offers rare transparency into a market that otherwise operates behind attorney-client privilege.

The mispricing is not that CRA trades cheaply in absolute terms. At 21.7x implied P/E (current price of $176.9 divided by FY2025 diluted EPS of $8.14), the stock is not obviously cheap. [FMP] CRAI: price $176.9, market cap $1.14B The mispricing is that standard screens have no framework for pricing expert witness reputation networks and therefore price them identically to strategy consulting, which carries lower switching costs and higher commoditization risk.

Capital Allocation

CRA has returned capital consistently while expanding its expert base. The diluted share count declined from 7.621 million shares in FY2021 to 6.714 million shares in FY2025 — a reduction of approximately 11.9% — consistent with sustained buyback activity that compounds per-share value without being visible in headline revenue growth.

The operating margin rose from 9.8% in FY2021 to 11.1% in FY2025 — with a contraction in FY2023 — suggesting that incremental revenue has flowed through at above-average margins over the full period. FY2025 operating income reached $83.1 million on $751.6 million in revenue. OCF of $22.4 million in FY2025 appears low relative to net income; over five years, accumulated OCF of approximately $233 million against net income of $225 million suggests no systematic earnings-quality concern. The annual OCF variation — ranging from $22.4 million to $75.7 million — is consistent with the timing patterns of compensation-heavy professional services firms; the data cache carries no working-capital line detail to confirm the precise mechanism.

Risks

Key-person risk is the structural ceiling on this thesis. CRA's competitive moat resides entirely in its expert witnesses — their academic credentials, courtroom track records, and law firm relationships. If a marquee economist with a multi-decade antitrust testimony track record departs for a private competitor or returns to academia, that relationship departs with them. CRA retains ownership of past case results but not the future credibility of an expert who has left. This risk does not appear in any financial metric and shows up only when revenues from specific practice areas decline unexpectedly. It is the primary reason this thesis should remain conditional rather than high-conviction. [SEC] CRA FY2025 10-K

CEO insider selling is a yellow flag. Paul Maleh's public Form 4 filings show a pattern of sell transactions over the past several years with no corresponding purchases. [SEC] CRAI Form 4 filings, SEC EDGAR This does not disqualify the thesis — executives sell for tax and diversification reasons — but the pattern is worth noting alongside the absence of open-market buys at a company whose chief executive should have a more informed view of intrinsic value than any outside analyst.

Antitrust enforcement cyclicality introduces demand risk. CRA's largest practice area depends on regulatory activity — merger reviews, cartel investigations, private litigation. A significant slowdown in DOJ/FTC enforcement posture or a reduction in complex litigation volume would reduce demand for antitrust expert witnesses in ways that trailing financial metrics do not predict.

Legal analytics and AI as a long-term substitution risk. The standard blind spot in expert-witness firm analysis is underweighting the pace of change in tools that could partially commoditize economic analysis. AI-assisted damages modeling and legal analytics platforms are improving. If opposing counsel can generate credible economic analyses more cheaply, the premium for human expert testimony may compress at the margin over a long enough horizon. This risk is not visible in current financials but belongs in a full risk accounting.

Information constraint. Revenue concentration by practice area and individual expert contribution are not separately disclosed — a consequence of CRA's single-segment reporting structure. This limits the precision of any moat assessment that relies on public financials alone.

Valuation

CRA trades at approximately 21.7x trailing earnings (price $176.9 divided by FY2025 diluted EPS $8.14) and 1.52x FY2025 revenue. A July 2026 Seeking Alpha analysis titled "Asking Price Is Steep" concluded the stock's valuation was steep at these levels — a position that is defensible on a pure growth-multiple basis. Revenue growing 7% annually with a net income margin of 7.3% does not mechanically justify a significant premium to general services firms.

The argument for holding above a market multiple requires accepting that expert witness networks carry durable switching costs that do not appear in standard metrics. If that is true — and there is no public pure-play peer to validate what the market assigns to switching costs in litigation economics — then the market may be pricing CRA as a generic consulting firm when its competitive structure is closer to a reputation network with consulting revenues attached. The spread between those two framings is where the potential re-rating lives.

If the thesis breaks — marquee expert departures, antitrust enforcement slowdown, or an earnings miss that forces a downward revision to the revenue growth assumption — the multiple compresses toward a generic services multiple appropriate for project-based consulting without structural switching costs.

Re-rating Catalyst

The coverage gap narrows through one of two paths. The first is an analyst initiation from a specialist covering legal markets or litigation services — a firm with a framework for pricing expert witness moats that generalist industrial analysts lack. That initiation would provide a vocabulary for CRA's competitive differentiation and route the name to institutional investors who can evaluate why an expert-witness franchise may warrant a different valuation framework than project-based consulting.

The second path is a high-profile case outcome where a CRA expert's testimony is credited by name in a significant antitrust verdict. Landmark decisions at the DOJ or in complex private litigation surface in the business press and in the legal community simultaneously. A single prominent win elevates CRA's brand in the law firm community in ways that are difficult to quantify but meaningful for future engagement pipelines.

International expansion opens a third path: European antitrust and digital markets enforcement (EU Digital Markets Act, EU cartel investigations) has expanded the addressable market for economic expert testimony outside North America. CRA operates offices across Europe and Asia-Pacific; a firm that was historically concentrated domestically generating sustained international revenue growth could attract coverage from European financial services analysts who follow regulatory economics.

The coverage gap that keeps CRAI at two analyst ratings is structural and unlikely to close through any single quarter's results. It closes when someone reframes the business — and when that framing reaches investors who have never had occasion to compare CRA with its private-market peers.